Prosus Ventures has reinvested in the commerce services provider through a round valuing it at $400m.
Author: Jordan Williams
Kaia Health stretches to $75m series C
The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.
OpenSpace snaps up $55m in series C round
JLL and New World Development have participated in a series C round for the construction imaging technology provider, which has increased its total funding to over $88m.
Caresyntax collects $100m of series C funding
Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.
Sera Prognostics sees its way to $100m
Funding from the Anthem-backed series E round will support the commercialisation of Sera’s biomarker tests, which predict the chances of preterm births.
Arch Oncology arranges $105m series C
The cancer therapy developer has now collected more than $240m altogether, having completed a series C round that included Roche Venture Fund.
Step climbs to $100m series C
Stripe has reinvested in the teenager-focused digital banking services provider, which also counts Sesame Workshop and WndrCo as existing backers.
Greenlight waves in Wells Fargo to raise $260m
Wells Fargo Strategic Capital was among the investors in a series D round valuing the child-focused banking platform developer at $2.3bn.
Koch assists Automox in $110m series C
Koch Disruptive Technologies returned to reinvest in the endpoint cybersecurity software provider, helping boost its overall funding to more than $152m.
Lockheed Martin finds Main Sequence for $194m fund
Lockheed Martin has returned to invest in Main Sequence Ventures’ second fundraise having previously committed to its Csiro-mandated first fund.
Scivita Medical selects corporates for series A
Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.
Saint-Gobain gravitates to Richland Capital
Saint-Gobain has contributed to Richland Capital’s third fund, joining fellow corporate investors Asahi Kasei and Solvay.
Vera Therapeutics vies for public markets spot
Alphabet and Merck Group could exit the immunological and inflammatory disease therapy developer in an offering with an $86.3m placeholder target.
Carlyle to capture Unchained Labs for $435m
Carlyle Group has agreed to pay $435m for the biologics research technology provider, which has raised $86m from investors including Novo.